Twitter | Pretraživanje | |
Pretraživanje Osvježi
BlackThorn Therapeutics 21. stu
Did you attend : What’s Next in Neuroscience Therapies? Our CMO Jane Tiller MD and Kristina Burow of ARCH Venture Partners presented our approach leveraging computational and clinical neuroscience to develop targeted therapeutics for CNS disorders.
Reply Retweet Označi sa "sviđa mi se"
Xconomy 23. sij
Reply Retweet Označi sa "sviđa mi se"
Xconomy 21. sij
Reply Retweet Označi sa "sviđa mi se"
Xconomy 19. stu
See you tomorrow! Explore new tech changing how we understand brain diseases/spinal injuries & novel approaches companies are taking to treat these conditions:
Reply Retweet Označi sa "sviđa mi se"
Big4Bio:SFBay 18. stu
At ’s What’s Next in Neuroscience, engage with scientists, entrepreneurs & other biotech leaders developing next-gen therapies/tech in spinal-cord injuries, mental health, addiction, dementia, Alzheimer's & more. Nov 19 in San Francisco:
Reply Retweet Označi sa "sviđa mi se"
Big4Bio:SFBay 13. stu
Brain disorders are among the toughest to diagnose/treat, but new approaches/tech could change everything. Join , , /, Alector, & more for What’s Next in Neuroscience - 11/19 in San Francisco:
Reply Retweet Označi sa "sviđa mi se"